| Hans-Günter Meyer-Thompson | Amphetamine
The impact of psychostimulant use on office based buprenorphine treatment retention.
The impact of psychostimulant use on office based buprenorphine treatment retention.
Edgerton R, Rebeiro P, MacMaster S, Bell L, Patel P, Ginn L, Beach K, Shah V, Cooper RL.
Harm Reduct J. 2025 Apr 12;22(1):51. doi: 10.1186/s12954-025-01201-3. PMID: 40221764; PMCID: PMC11992809.